A new malaria vaccine has become the first in tests to be 100% effective in providing protection against the deadly disease. The promising results provide hope for a future cure.
Sanaria, a company in Rockville, Maryland, developed the vaccine, called PfSPZ, which uses a weakened form of the malaria organism to instigate a response from the immune system.
(READ the story in the NY Daily News)
Photo credit: Gates Foundation